Nuo Therapeutics, Inc. (AURX)

Nuo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.55	0.28	0.93	2.05	1.41
Cash & Short-Term Investments	0.55	0.28	0.93	2.05	1.41
Cash Growth	93.49%	-69.45%	-54.73%	45.01%	776.26%
Accounts Receivable	0.56	0.25	0.25	0.09	-
Receivables	0.56	0.25	0.25	0.09	-
Inventory	0.21	0.15	0.21	0.24	-
Prepaid Expenses	0.06	0.16	0.17	0.2	0.05
Restricted Cash	-	-	-	0.06	-
Total Current Assets	1.38	0.84	1.56	2.63	1.47
Property, Plant & Equipment	0.47	0.35	0.31	0.41	-
Total Assets	1.85	1.19	1.88	3.05	1.47
Accounts Payable	0.44	0.22	0.39	0.4	0.53
Accrued Expenses	0.49	0.29	0.19	0.12	0.15
Current Portion of Leases	0.08	0.07	0.09	0.08	-
Current Unearned Revenue	0.3	-	-	-	-
Total Current Liabilities	1.31	0.58	0.67	0.6	0.67
Long-Term Leases	0.02	0.1	0.16	0.26	-
Long-Term Unearned Revenue	0.98	-	-	-	-
Other Long-Term Liabilities	0.5	-	-	-0	-
Total Liabilities	2.8	0.68	0.84	0.86	0.67
Common Stock	0	0	0	0	0
Additional Paid-In Capital	33.81	32.77	30.97	28.95	24.38
Retained Earnings	-34.77	-32.26	-29.94	-26.76	-23.59
Total Common Equity	-0.96	0.51	1.04	2.19	0.79
Shareholders' Equity	-0.96	0.51	1.04	2.19	0.79
Total Liabilities & Equity	1.85	1.19	1.88	3.05	1.47
Total Debt	0.1	0.16	0.26	0.34	-
Net Cash (Debt)	0.45	0.12	0.67	1.72	1.41
Net Cash Growth	277.88%	-82.25%	-60.78%	21.32%	776.26%
Net Cash Per Share	0.01	0.00	0.02	0.04	0.05
Filing Date Shares Outstanding	48.29	46.82	44.24	41.8	37.12
Total Common Shares Outstanding	48.18	46.82	44.24	41.8	37.12
Working Capital	0.07	0.26	0.89	2.03	0.79
Book Value Per Share	-0.02	0.01	0.02	0.05	0.02
Tangible Book Value	-0.96	0.51	1.04	2.19	0.79
Tangible Book Value Per Share	-0.02	0.01	0.02	0.05	0.02
Machinery	0.88	0.61	0.45	0.45	0.39

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.